Literature DB >> 7817227

Clinical experience with 180 inflatable penile prostheses.

E R Randrup1.   

Abstract

I present my experience with 180 inflatable penile prostheses inserted in 167 patients with organic sexual impotence of 4 months to 30 years in duration. Mean age was 59.3 years. Prostheses used were AMS 700 (9), Flexiflate (14), Mentor Mark II (99), and Mentor Alpha I (58). Mean follow-up was 43.5 months. Overall complication rate was 17.8% (32 cases). In 24 cases, the complications were major (infection, malfunction, and extrusion) and necessitated reoperation. The remaining complications (8 cases) were minor (partial deviation, autoinflation), and surgical intervention was not needed. Staphylococcus epidermidis was the offending microorganism in 7 of 9 infections. In general, my results with these penile prosthesis implants suggest that they are a valid form of treatment for organic impotence.

Entities:  

Mesh:

Year:  1995        PMID: 7817227     DOI: 10.1097/00007611-199501000-00006

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Penile prosthesis implantation in Chinese patients with severe erectile dysfunction: 10-year experience.

Authors:  Wei-Dong Song; Yi-Ming Yuan; Wan-Shou Cui; Alex K Wu; Yi-Chen Zhu; Jing Liu; Lin Wang; Guang-Yi Bai; Jing Peng; Zhi-Chao Zhang; Bing Gao; Ying-Lu Guo; Tom F Lue; Zhong-Cheng Xin
Journal:  Asian J Androl       Date:  2013-07-22       Impact factor: 3.285

Review 2.  Penile prosthesis coating and the reduction of postoperative infection.

Authors:  Robert Abouassaly; Drogo K Montague
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 2.862

Review 3.  Penile prosthesis implant: scientific advances and technological innovations over the last four decades.

Authors:  Eric Chung
Journal:  Transl Androl Urol       Date:  2017-02

4.  Risk factors associated with penile prosthesis infection: systematic review and meta-analysis.

Authors:  Alejandro Carvajal; Johana Benavides; Herney Andrés García-Perdomo; Gerard D Henry
Journal:  Int J Impot Res       Date:  2020-02-03       Impact factor: 2.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.